INTRODUCTION {#SEC1}
============

Genomic instability in the form of chromosomal aberrations, gene amplification and loss of heterozygosity (LOH) are commonly found in various types of cancer ([@B1],[@B2]). DNA double-strand breaks (DSBs) that are generated endogenously or by exogenous sources are considered as the primary cause of chromosome instability ([@B3],[@B4]). DSBs that arise during replication are preferentially repaired by sister chromatid recombination (SCR) ([@B5]), a recombinational repair pathway that utilizes neighbouring intact sister chromatid as a template. Since the copied information is accurate, SCR is potentially an accurate pathway in repairing the DSBs and in maintaining the genome integrity ([@B6]--[@B8]). Tumor suppressor genes such as *BRCA1, BRCA2, RAD51C* and *XRCC2* have been shown to control DSB repair by SCR ([@B9]--[@B12]), implying that dysregulation in SCR could lead to tumorigenesis.

Fanconi anemia (FA) pathway plays an important role in the repair of DNA inter-strand crosslinks (ICLs). To date, 21 genes including *BRCA1, BRCA2* and *FANCJ* have been identified to participate in the FA pathway of ICL repair ([@B13]--[@B15]). FANCJ helicase was originally identified as a BRCA1 interacting C-terminal helicase (BACH1) ([@B16]), and was subsequently identified as a gene mutated in the J complementation group of FA ([@B17]--[@B19]), a rare chromosome instability genetic disorder characterized by bone marrow failure, skeletal abnormalities and predisposition to various types of cancer ([@B20]--[@B22]). In addition, monoallelic mutations in *FANCJ* confer familial breast and ovarian cancer similar to *BRCA1* and *BRCA2* germline mutations but with lower penetrance ([@B23]--[@B25]). FANCJ localizes to the sites of DSBs ([@B16],[@B26]), and cells deficient in FANCJ exhibit significant sensitivity to DSB inducing agents ([@B19],[@B27]--[@B29]). A biochemical study shows that FANCJ helicase unwinds D-loop ([@B30]), an intermediate in the homologous recombination (HR) pathway of DSB repair. Direct measurement of HR by a reporter also indicates that FANCJ participates in the repair of DSBs ([@B19]). Recent studies imply that FANCJ participates in the generation of ssDNA for the initiation of HR ([@B29]). Given that FANCJ unwinds D-loop structures ([@B30]), it is likely that FANCJ may also participate in the termination of HR by promoting synthesis dependent strand annealing (SDSA) mechanism of DSB repair. However, the precise role and the mechanism by which FANCJ participates in the repair of DSBs via HR remains elusive.

In mammalian cells, gene conversions typically extend \<100 bp termed short-tract gene conversions (STGC) ([@B31]--[@B33]). However, minority of HR events entail several kilobases of nascent strand synthesis that are defined as long-tract gene conversions (LTGC) ([@B11],[@B34],[@B35]). LTGC is an error-prone form of HR as it could lead to tandem gene duplication and gene amplifications that are frequently found in many types of cancer ([@B35],[@B36]). Mammalian cells lacking RAD51 paralogs (RAD51C, XRCC2 and XRCC3) exhibit reduced HR and an increased frequency of LTGC events in response to I-SceI endonuclease induced DSBs ([@B10],[@B11]). Notably, the BRCA1 tumor suppressor has been shown to suppress LTGC at a site specific replication fork barrier as well as at I-SceI induced DSBs ([@B5],[@B9]). However, the molecular mechanism by which RAD51 paralogs or BRCA1 control mammalian gene conversions (GC) is unclear. Here, using a previously characterized SCR reporter, we demonstrate that FANCJ deficient human and hamster cells exhibit a reduction in overall GC. Notably, GC tracts were biased in favour of LTGC in FANCJ depleted cells compared to control cells. Qualitative analysis shows that *GFP*-triplication, an outcome of LTGC was abundantly present in FANCJ depleted cells. Our analyses of FANCJ mutant that is deficient in its interaction with BRCA1 and helicase dead mutants reveal mechanistic insights into the fine balance of STGC and LTGC at the damaged chromatin. Moreover, cells expressing FANCJ pathological mutants exhibited defective SCR with an increased frequency of LTGC. Collectively, our data reveal that FANCJ dysfunction leads to aberrant amplification during SCR which might contribute to FA and breast/ovarian cancer predisposition.

MATERIALS AND METHODS {#SEC2}
=====================

Cell lines, cell culture and transfections {#SEC2-1}
------------------------------------------

U2OS SCR18, U2OS SCR 35S and V79B SCR55 were grown in Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37°C in humidified air containing 5% CO~2~. All plasmid transfections for transient expression in U2OS SCR18 and U2OS SCR35S were performed at 300 V and 950 μF and in V79B SCR55 at 250V and 950 μF using a Bio-Rad Gene Pulsar X cell.

DNA constructs {#SEC2-2}
--------------

The pcDNA3-myc-His FANCJ cDNA was a kind gift from Dr. Sharon Cantor. FANCJ shRNA\#1 and \#2 constructs (pRS shFANCJ) were generated using the previously reported sequences ([@B16]) ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) and cloned into the pRS shRNA vector. FANCM and BRCA1 shRNA plasmids were generated using the previously reported sequences ([@B37],[@B38]) ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) and cloned into the pRS shRNA vector. Hemagglutinin (HA)-6xHis-tagged human wild-type (wt) FANCJ and its mutant constructs were generated by overlap extension PCR method using primers sequences indicated in [Supplementary Table S2](#sup1){ref-type="supplementary-material"} and cloned into the modified pcDNA3β vector using EcoRV and XhoI restriction sites. The FANCJ shRNA resistant wt and mutant constructs were designed by introducing silence mutations in the FANCJ shRNA\#1 sequence ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). These primers were used for restriction free cloning with PfuTurbo polymerase. The design and construction of SCR reporter and I-SceI expression vector has been described previously ([@B35]).

Cell survival assays {#SEC2-3}
--------------------

Cell survival assays were carried out as described previously ([@B39]). Briefly, cells were mock-treated or treated with MMC for 6--8 h, followed by recovery in fresh medium. 4--5 days post recovery, cell survival was monitored by MTT assay using microplate reader (VersaMax ROM version 3.13). Percent cell survival was calculated as treated cells/untreated cell × 100.

G2/M accumulation assay {#SEC2-4}
-----------------------

G2/M accumulation assays were carried out as described previously ([@B12]). Exponentially growing U2OS cells transfected with either control shRNA or FANCJ shRNA plasmids were incubated in 100 ng/ml MMC for 6--8 h and later recovered in fresh media. For rescue experiments, the wt FANCJ construct was transfected 24 h post FANCJ shRNA plasmid transfection followed by incubation in MMC. 48--72 h post recovery, cells were collected and single-cell suspensions were fixed overnight with 70% ethanol in PBS at --20°C. After centrifugation, the cells were incubated with 0.10 mg/ml RNaseA (Fermentas) in PBS at 42°C for 4 h and then incubated for 10 min with propidium iodide (PI) (1 mg/ml) in the dark. A total of 1 × 10^4^ cells were analysed by Verse flow cytometer (BD Biosciences). Aggregates were gated out, and percentages of cells with 2N and 4N DNA content were calculated using FACSDiva version 6.1.1 software (BD Biosciences).

Recombination assays {#SEC2-5}
--------------------

HR assays were performed as described previously ([@B11]). In brief, U2OS SCR18 cells were transfected with either FANCJ shRNA plasmid or various FANCJ cDNAs (WT or mutant) or control pcDNA3β vector. After 24 h, 2 × 10^6^ cells were further transfected with 24 μg of I-SceI expression plasmid. Forty eight hours later, GFP^+^ cells were scored by FACS analysis using BD biosciences Verse flowcytometer. In each experiment, the percentage of GFP^+^ cells (either I-SceI induced or uninduced) was measured in triplicate samples, and I-SceI-transfected values were corrected for transfection efficiency (∼60--70%). The spontaneous GFP^+^ frequency (\<0.01%) was subtracted from this value to obtain the I-SceI-induced GFP^+^ frequency. To quantitatively analyze the SCR events, U2OS SCR18 cultures transiently transfected with either I-SceI or control pcDNA3β vector, were trypsinized, counted, and replated at 2 × 10^5^ to 4 × 10^5^ cells per 10 cm plate. 24 h post plating, 10 μg/ml blasticidin (BSD) was added and colonies were selected for 2 weeks. Later, the cells were fixed with fixative (ethanol:acetone), stained with crystal violet and the colonies were counted for analysis. Plating efficiency was determined in parallel for each experiment by plating defined numbers of cells, allowing colonies to form without antibiotic selection. The absolute I-SceI induced BsdR^+^ frequency was corrected for transfection efficiency and plating efficiency, followed by negating the spontaneous BsdR^+^ frequency (was always \<0.001%). To qualitatively analyse the SCR events, Southern blotting was performed as described previously ([@B11]). In U2OS SCR35S cells, GFP^+^ and GFP^+^ RFP^+^ frequencies were measured 72 h post-transfection by FACS using BD FACS ARIA FUSION in triplicates and corrected for transfection efficiency and background events. Data represent the mean of at least three independent experiments with SD values indicated by error bars. Statistical analysis was by two-tailed paired *t*-test (unknown variance).

Crossover/non crossover recombination analysis {#SEC2-6}
----------------------------------------------

Crossover/non crossover recombination events were analysed as described previously ([@B11]). Briefly, I-SceI transfected U2OS SCR18 cells were plated at a density of 5 × 10^5^ cells per 15 cm dishes to yield single-cell colonies. 48 h later, cells were pulse treated (24 h) with 10 μg/ml BSD and subsequently grown in normal media lacking BSD. After two weeks, sectored colonies containing GFP^+^ and GFP^−^ cells were identified by microscopic screening and these colonies were isolated and expanded for Southern blotting analysis.

Immunoprecipitation, western blotting and antibodies {#SEC2-7}
----------------------------------------------------

Immunoprecipitation and immunoblotting was carried out as described previously ([@B40]). Briefly, cells were harvested and lysed in NTEN buffer (0.5% NP40, 50 mM Tris--HCl pH 8.0, 2 mM EDTA, 150 mM NaCl and 10% glycerol) supplemented with a complete protease inhibitor cocktail (Roche). For the immunoprecipitation assays, 1mg protein from the cell lysates was incubated with anti-HA (Roche) antibody and separated using protein G beads. The proteins were resolved on a 6% SDS-PAGE gel and transferred onto PVDF membrane (Millipore). The membranes were blocked using 5% skimmed milk in TBST buffer (50 mM Tris--HCl pH 8.0, 150 mM NaCl, and 0.1% Tween-20) and incubated with primary antibody for 12 h at 4°C. The primary antibodies against FANCM (1:50, sc-101389), BRCA-1 (1:100, sc-6954), MCM3 (1: 500, sc-365616) that were used for western blot analysis were purchased from Santa Cruz. Anti-MRE11 (1:2000, 611366) antibodies were obtained from BD Biosciences; and the rabbit polyclonal antibody for FANCJ (1:1000, ab49657) was obtained from Abcam. Anti-HA antibody (1:2000, 12CA5) was obtained from Roche. The membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies, developed by chemiluminescence, and imaged using Chemidoc (GE healthcare LAS 4000).

RESULTS {#SEC3}
=======

FANCJ controls the fine balance between STGC and LTGC {#SEC3-1}
-----------------------------------------------------

To study SCR in mammalian cells, a reporter was designed and constructed as described previously ([@B35]) (Figure [1A](#F1){ref-type="fig"}). The SCR reporter contains two mutated copies of the gene encoding GFP; the first one is 5′ truncated and the second one is full length but is interrupted by the insertion of 18 bp I-SceI recognition site. I-SceI induced gene conversion generates wt *GFP*, and the GFP^+^ cells can be quantified by flow cytometry. HR mediated STGC could arise by intrachromatid or interchromatid recombination. As earlier proposed ([@B34],[@B41]), *GFP*-triplication could arise by LTGC or crossing over during SCR. However, crossover associated recombination events are highly suppressed in somatic cells ([@B9],[@B11],[@B34]). Thus, *GFP-*triplication in our assay reflects SCR/LTGC events. To distinguish between STGC and LTGC (*GFP*-triplication), two artificial exons (A and B) coding for blasticidin (BSD) resistance gene *BsdR* were introduced in a non-productive orientation between two *GFP* copies. In the context of STGC, SCR reporter remains un-rearranged and the cell remains sensitive to BSD (BsdR^--^) (Figure [1A](#F1){ref-type="fig"}, outcome 1). However, the GC tract of ≥ 1,031 bp results in the duplication of the *BsdR* exon B, allowing splicing between exon A with neighboring duplicated exon B to generate wt*BsdR* mRNA, rendering the cell resistant to BSD (BsdR^+^) (Figure [1A](#F1){ref-type="fig"}, outcome 2). If the GC extends ≥ 3, 250 bp, it results in *GFP*-triplication, duplicating the entire *BsdR* cassette (Figure [1A](#F1){ref-type="fig"}, outcome 3). The distinction of STGC and LTGC in our assay entails a GC of \<1,031 bp for STGC and \>1,031 bp for LTGC.

![FANCJ dysfunction skews gene conversion in favour of LTGC. (**A**) Structure of the SCR reporter. Filled arrow heads represent promoters corresponding to *GFP* and *BsdR* cassette. The circles depict 5′ and 3′ exon of *BsdR* cassette. The diagram shows two sister chromatids engaged in unequal SCR. The three outcomes of I-SceI induced SCR are shown: gene conversion that terminates before copying *BsdR* exon B (1, STGC); gene conversion that duplicates *BsdR* exon B but terminates prior to generating a third *GFP* copy (2, LTGC/early termination); and gene conversion that duplicates entire *BsdR* cassette, generating a third *GFP* copy (3, LTGC/*GFP* triplication). Wild-type *GFP* is shaded in green and wt*BsdR* mRNA is shaded in orange. Tr *GFP*, truncated *GFP*. (**B**) I-SceI induced GFP^+^ frequencies (total GFP; overall GC) in control shRNA, FANCJ shRNA\#1, FANCJ shRNA\#2, FANCJ shRNA\#1 and its resistant wtFANCJ (r) and FANCM depleted U2OS SCR18 cells. (**C**) Frequencies of I-SceI induced BsdR^+^ colonies for the same experiment shown in panel B. (**D**) Ratio of I-SceI-induced BsdR^+^/GFP^+^ frequencies (LTGC/overall GC, expressed as a percentage) from the experiment whose results are shown in panels B and C. (**E**) Immunoblotting for FANCJ and FANCM protein levels after depletion of FANCJ and FANCM.](gkx586fig1){#F1}

To investigate whether FANCJ controls the fine balance between STGC and LTGC, we used previously established U2OS (U2OS SCR18) cells containing a single chromosomally integrated SCR reporter. Transient transfection of U2OS SCR18 cells with hFANCJ shRNA plasmids (FANCJ shRNA\#1 and FANCJ shRNA\#2) yielded maximum depletion of endogenous FANCJ which resulted in heightened sensitivity and G2/M accumulation upon mitomycin C (MMC) induced ICL damage ([Supplementary Figure S1A and S1D](#sup1){ref-type="supplementary-material"}). To authenticate the specificity of shRNAs in depleting FANCJ, we generated shRNA\#1 resistant construct (wt-FANCJ(r)). Western blotting analysis revealed that expression of wt-FANCJ(r) (HA-6xHis-FANCJ) was very similar to endogenous levels of FANCJ ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}). Transfection with FANCJ shRNA \#1(r) construct rescued U2OS cells from MMC induced DNA damage sensitivity and G2/M accumulation ([Supplementary Figure S1B and S1D](#sup1){ref-type="supplementary-material"}). I-SceI induced overall GC is measured by GFP^+^ cells. The I-SceI induced BsdR^+^ (LTGC) events are a subset of I-SceI induced GFP^+^ cells. Hence, the ratio of BsdR^+^ GFP^+^ cells to the overall GFP^+^ cells (LTGC/overall GC) represents the I-SceI induced GC resolving as LTGC. This ratio was found to be between 5% and 7% in mammalian cells ([@B10],[@B11],[@B42]). To study the HR efficiency, FANCJ depleted with shRNA\#1 and control vector cells were transfected with I-SceI encoding plasmid, and 48 h after transfection, GFP^+^ cells were measured by flow cytometry. Depletion of FANCJ caused \>3 fold reduction in GFP^+^ cells (\<1%) compared to control cells (∼4%) (Figure [1B](#F1){ref-type="fig"}). The decrease in HR was rescued by transfecting the cells with FANCJ shRNA \#1(r) plasmid (Figure [1B](#F1){ref-type="fig"}). Interestingly, although there was \>3-fold reduction in HR frequency in FANCJ depleted cells, the absolute BsdR^+^ events were very similar to control cells (Figure [1C](#F1){ref-type="fig"}). The ratio of BsdR^+^ GFP^+^ events/total GFP^+^ events, a direct measure of LTGC was ∼5% in control cells. Strikingly, this ratio was increased to 6--8-fold in FANCJ depleted U2OS cells (Figure [1D](#F1){ref-type="fig"}). Consistently, transfection of cells with FANCJ shRNA \#1(r) plasmid was able to rescue elevated LTGC events in FANCJ depleted cells (Figure [1D](#F1){ref-type="fig"}). We tested whether depletion of FANCM, another helicase/translocase in the FA pathway affects the balance of STGC and LTGC. Consistent with earlier report ([@B43]) depletion of FANCM caused significant reduction in overall HR (Figure [1E](#F1){ref-type="fig"}, lower panel and [1B](#F1){ref-type="fig"}). Interestingly, LTGC ratio was very similar to control cells in FANCM depleted cells, indicating that FANCJ but not FANCM controls the LTGC bias (Figure [1B](#F1){ref-type="fig"}--[D](#F1){ref-type="fig"}). To validate our observation, we used U2OS cells that contain SCR reporter (U2OS SCR35S) where STGC and LTGC can be directly measured by FACS analysis ([@B9]). In this reporter, *BsdR* cassette was replaced by RFP encoding cassette and both overall GC and LTGC can be measured by scoring for GFP^+^ and GFP^+^ RFP^+^ cells, respectively. Using this modified SCR reporter, we made a similar observation as that of U2OS SCR18 cells ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). These data suggest that FANCJ controls the overall GC and suppress LTGC during SCR.

FANCJ is a highly conserved protein in metazoans with a 74% and 75% identity of mouse and hamster FANCJ with human FANCJ, respectively ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). To test whether hamster FANCJ controls SCR, we depleted FANCJ in previously characterized V79B SCR55 cells ([@B11]) and measured the SCR outcome. FANCJ depletion was maximal similar to U2OS cells ([Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}), and upon depletion, these cells were sensitive to MMC ([Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}). In response to I-SceI induced DSBs, control cells displayed \>0.3% GFP^+^ cells. In contrast, a 3-fold reduction in overall GC was observed in FANCJ deficient cells ([Supplementary Figure S4B](#sup1){ref-type="supplementary-material"}). Interestingly, although the frequency of BsdR^+^ cells in FANCJ depleted cells was similar ([Supplementary Figure S4C](#sup1){ref-type="supplementary-material"}), the probability of GC resolving as LTGC was elevated ∼5-fold in FANCJ depleted cells when compared with control shRNA and FANCJ shRNA(r) transfected cells ([Supplementary Figure S4D](#sup1){ref-type="supplementary-material"}). These results clearly suggest that FANCJ helicase controls the fine balance of STGC and LTGC during I-SceI induced SCR.

FANCJ deficient cells exhibit qualitative alterations in LTGC products {#SEC3-2}
----------------------------------------------------------------------

The GC tract that involves copying *BsdR* exon B (1031 bp) but is terminated before duplicating the third *GFP* copy represent early terminating LTGC events (LTGC/early termination). However, tract lengths extending ≥3.2 kb generate *GFP*-triplication (LTGC/*GFP*-triplication). We can distinguish 'early terminating LTGC' versus '*GFP*-triplication' events within SCR reporter by Southern blot analysis of BsdR^+^ colonies. Figure [2A](#F2){ref-type="fig"} shows the expected restriction fragments of SCR reporter in Southern blots hybridized with a *GFP* cDNA probe for the parental reporter (Figure [2A](#F2){ref-type="fig"}, upper panel), for an early terminating LTGC (Figure [2A](#F2){ref-type="fig"}, middle panel) and for the *GFP*-triplication outcome (Figure [2A](#F2){ref-type="fig"}, lower panel).

![FANCJ depletion induces qualitative dysregulation in the SCR events. (**A**) Structure of the SCR reporter and the predicted DNA fragment sizes in Southern blotting using *GFP* cDNA probe from the parental (upper panel), LTGC/early termination (middle panel) and LTGC/*GFP*-triplication (lower panel) outcomes. P, PstI; H, HindIII; S, SacI; E, EcoRI; puro, puromycin; *Tr-GFP*, truncated *GFP*. (**B**) Southern blot analysis of parental U2OS SCR18 clone, lanes 1 and 3; a *GFP*-triplication outcome in FANCJ depleted and control cells (lanes 2 and 5) and LTGC/early termination event that was predominantly seen in control cells (lane 4). The lane numbers in each panel represents the same clone. The restriction enzymes used are shown under each panel. (Left panel) P, PstI digest; P/I, PstI + I-SceI digest; open arrowhead, 1.3-kb fragment released by PstI + I-SceI double digestion. In digests with EcoRI and HindIII the filled arrowhead indicates a 3.2-kb amplification product corresponding to duplication of part or all of the *BsdR* cassette. 'L' and 'R' indicate left and right arms of the reporter, respectively. (**C**) Gene conversion tract length frequency distribution in FANCJ depleted and control cells. Relative frequencies of I-SceI induced early terminating LTGC (green) and *GFP*-triplication (blue) events in FANCJ deficient and control cells. The number in parentheses shows the number of colonies analyzed. (**D**) Mean frequencies of gene conversion tract lengths in FANCJ depleted (blue bars) and control cells (red bars). These frequencies are obtained by combining the data shown in [Supplementary Figure S5A, S5C](#sup1){ref-type="supplementary-material"} and Figure [2C](#F2){ref-type="fig"} to indicate relative frequencies of STGC, LTGC/early termination and LTGC/*GFP*-triplication.](gkx586fig2){#F2}

To test whether FANCJ depleted cells show qualitative dysregulation in LTGC, we examined I-SceI induced BsdR^+^ colonies from FANCJ depleted and control cells. Digestion of parental SCR reporter with PstI generates 5.9 kb fragment, whereas PstI and I-SceI yield 4.6 and 1.3 kb fragments (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}, lane 1 and 3). Either EcoRI or SacI digests generate two bands of varying length corresponding to 'left' and 'right' arm of the SCR reporter (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}, lane 1 and 3). HindIII digestion generates a 3.05 kb of left arm and a varying fragment of right arm (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}, lane 1 and 3). In the context of *GFP*-triplication, the size of PstI increases to 9.1 kb and the PstI + I-SceI digestion yields 7.8 and 1.3 kb fragments (Figure [2A](#F2){ref-type="fig"}, lower panel and B, lanes 2 and 5). The presence of intact I-SceI site in the third *GFP* indicates that *GFP*-triplication event occurred by SCR, since I-SceI site will be lost after the generation of DSB. Digestion with EcoRI, SacI or HindIII generates unperturbed left and right arms and a 3.2 kb fragment corresponding to the duplication of *Bsd*R cassette. A proportion of LTGC events can get terminated prior to copying the third *GFP* (\<2.9 kb) which are termed as 'early terminating' LTGC events that are characterized by shorter PstI fragment, absence of I-SceI site and loss of right arm of the reporter (Figure [2A](#F2){ref-type="fig"}, middle panel and B, lane 4).

Data shown in [Supplementary Figure S6](#sup1){ref-type="supplementary-material"} and Figure [2C](#F2){ref-type="fig"} shows that in the control cells, 67.5% of LTGC events were early terminating and 32.5% entailed *GFP*-triplication. Strikingly, in the FANCJ depleted cells, LTGC events predominantly resolved as *GFP*-triplications (57.5%). Taking data from [Supplementary Figure S5](#sup1){ref-type="supplementary-material"} and Figure [2C](#F2){ref-type="fig"}, we derived frequencies of SCR associated STGC (tract length of \<1 kb), early terminating LTGC (tract length between 1 and 3.2 kb) and *GFP*-triplication events (tract length of \>3.2 kb) in control and FANCJ depleted cells (Figure [2D](#F2){ref-type="fig"}). As shown in Figure [2D](#F2){ref-type="fig"}, 76% of GC events represented STGC in FANCJ depleted cells compared to ∼97% in control cells. The 24% of LTGC events that were observed in FANCJ depleted cells resulted predominantly in *GFP*-triplication outcome. In contrast, two-thirds of LTGC events entailed early terminating LTGC events, and one-third resolved as *GFP*-triplications in control cells (Figure [2D](#F2){ref-type="fig"}). These data clearly suggests that FANCJ plays a crucial role in the regulation of GC and limits the extent of copying during SCR.

*GFP*-triplication in FANCJ depleted cells arises by LTGC {#SEC3-3}
---------------------------------------------------------

Elevated *GFP*-triplication events that were observed in FANCJ depleted cells could arise by crossover (CO) recombination between sister chromatids or by LTGC. CO between sister chromatids alters the structure of donor sister by truncation of *GFP* reporter (Figure [3A](#F3){ref-type="fig"}). However, LTGC mechanism of *GFP*-triplication arises by extended copying during repair synthesis leaving the donor sister chromatid intact (Figure [3A](#F3){ref-type="fig"}). We captured the donor sister cells after pulse exposure to blasticidin as described previously ([@B11]). Using this method we retrieved 19 sectored (GFP+/GFP--) colonies from control cells and 18 sectored colonies from FANCJ depleted cells. These colonies were subjected to Southern blotting analysis using PstI digested genomic DNA. In control cells, 6/19 (31.5%) colonies exhibited bands corresponding to 9 and 6 kb, indicating LTGC mediated *GFP*-triplications; 12/19 (63.1%) colonies revealed ∼8 and 6 kb bands corresponding to early terminating LTGC events and 1/19 (5.2%) showed a CO recombination event with 9 and 2.9 kb fragments (Figure [3B](#F3){ref-type="fig"} and [C](#F3){ref-type="fig"}). In FANCJ depleted cells, 61% of colonies (11/18) exhibited 9 and 6 kb bands, suggesting that *GFP*-triplications arises by LTGC; 33.3% (6/18) colonies revealed early terminating events and 1/18 (5.6%) showed CO recombination product (Figure [3B](#F3){ref-type="fig"} and [C](#F3){ref-type="fig"}). These data clearly indicate that *GFP*-triplications that were abundantly seen in FANCJ depleted cells arise by LTGC.

![Analysis of crossover and non-crossover SCR events in U2OS SCR18 cells. (**A**) Illustration of crossover and LTGC products during SCR. (**B**) Southern blotting analysis of PstI digested sectored GFP+/GFP-- colonies from control (left panel) and FANCJ depleted cells (right panel). Images depict representative ten colonies each from control and FANCJ depleted cells. (**C**) Frequency distribution of *GFP*-triplication, early termination and crossover recombination events during SCR in control and FANCJ depleted cells.](gkx586fig3){#F3}

The SCR regulation by FANCJ is BRCA1 dependent {#SEC3-4}
----------------------------------------------

BRCA1 plays an upstream role in the repair of DSBs by HR ([@B44]). BRCA1 dysfunction skews GC in favor of LTGC-associated *GFP*-triplication events ([@B9]). To understand whether FANCJ functions in the BRCA1 pathway of LTGC suppression, we examined SCR events by depleting BRCA1 and FANCJ independently and by co-depletion. Compared to FANCJ depleted cells, BRCA1 depletion caused more severe HR defect (Figure [4A](#F4){ref-type="fig"}). However, co-depletion of BRCA1 and FANCJ had similar reduction in HR as that of BRCA1 alone depleted cells (Figure [4A](#F4){ref-type="fig"} and [D](#F4){ref-type="fig"}), implying that FANCJ has a downstream role in BRCA1 mediated HR regulation. Consistent with earlier study ([@B9]), BRCA1 dysfunction resulted in LTGC bias and the LTGC frequency was 2--3 folds higher than FANCJ depleted cells (Figure [4C](#F4){ref-type="fig"}). However, this increase in LTGC was very similar to FANCJ and BRCA1 co-depleted cells (Figure [4C](#F4){ref-type="fig"}), suggesting that FANCJ participate in BRCA1 mediated HR and in controlling the balance between STGC and LTGC.

![FANCJ and BRCA1 function in a common pathway to suppress LTGC. (**A**) I-SceI induced GFP^+^ frequencies in control shRNA, FANCJ and BRCA1 single and co-depleted cells. (**B**) Frequencies of I-SceI induced BsdR^+^ colonies for the same experiment shown in panel A. (**C**) Ratio of I-SceI-induced LTGC/overall GC from the experiment whose results are shown in panels A and B. (**D**) BRCA1 and FANCJ protein levels after depletion of BRCA1 and FANCJ, respectively.](gkx586fig4){#F4}

FANCJ S990 is known to undergo phosphorylation by CDK and this phosphorylation is required for FANCJ interaction with BRCA1 ([@B45]) (Figure [5A](#F5){ref-type="fig"}). However, the precise role of FANCJ interaction with BRCA1 during HR is unclear. To address this, we generated FANCJ shRNA\#1 resistant FANCJ S990A and a phosphomimicking FANCJ S990E mutant as described in materials and methods. The steady state levels of both the mutants were comparable to wt FANCJ levels (Figure [5B](#F5){ref-type="fig"}). Our immunoprecipitation studies revealed that FANCJ S990A was defective with BRCA1 interaction (Figure [5B](#F5){ref-type="fig"}). In contrast, FANCJ S990E was partially competent to interact with BRCA1 (Figure [5B](#F5){ref-type="fig"}). FANCJ Q944E pathological mutant was identified in a breast cancer patient ([@B46]) and this mutation is located close to the site of S990 which undergoes phosphorylation and interacts with BRCT domain of BRCA1. Although FANCJ Q944E mutant protein levels were comparable to wt FANCJ, this mutant was defective with BRCA1 interaction. In agreement with a previous study ([@B47]), all the mutants were proficient in interacting with MRE11 (Figure [5B](#F5){ref-type="fig"}). Next, we examined the role of these FANCJ mutants in SCR regulation. After 24 h of FANCJ depletion, FANCJ mutant plasmids were co-transfected with I-SceI expression plasmids and SCR events were analysed. Interestingly, transient expression of FANCJ S990A caused a ∼4-fold reduction in overall GC and ∼5-fold increase in LTGC compared to control shRNA or wt FANCJ (r) cells (Figure [5C](#F5){ref-type="fig"}--[E](#F5){ref-type="fig"}). The FANCJ S990E that retained partial interaction with BRCA1 exhibited significant reduction in HR and increase in LTGC (Figure [5C](#F5){ref-type="fig"}, [D](#F5){ref-type="fig"} and [E](#F5){ref-type="fig"}). In contrast, FANCJ Q944E that was incompetent to bind BRCA1 exhibited ∼5 fold reduction in I-SceI induced HR compared to control cells (Figure [5C](#F5){ref-type="fig"}). Interestingly, expression of this mutant skewed the HR toward \>5-fold increase in LTGC compared to control cells (Figure [5E](#F5){ref-type="fig"}). Together, these results suggest that FANCJ interaction with BRCA1 is crucial for the FANCJ mediated overall HR and in suppressing LTGC.

![SCR regulation by FANCJ is dependent on its interaction with BRCA1. (**A**) Schematic diagram of FANCJ depicting the conserved helicase domains (I--VI), NLS motif, Fe-S cluster and the BRCA1 binding domain. The S990 phosphorylation site and breast cancer associated Q944E residue is indicated. (**B**) Interaction of BRCA1 with wt and FANCJ mutants in the U2OS SCR18 cells. HA-6xHis-FANCJ was measured using HA specific antibody. (**C**) I-SceI induced GFP^+^ frequencies in U2OS SCR18 cells transfected with FANCJ shRNA\#1 along with empty vector (EV) and the plasmids that express FANCJ shRNA resistant wtFANCJ, FANCJ S990A, FANCJ S990E and FANCJ Q944E. (**D**) Absolute frequencies of BsdR^+^ colonies for the experiment shown in panel C. (**E**) Ratio of LTGC:Overall GC obtained from the data shown in panels C and D.](gkx586fig5){#F5}

FANCJ ATPase/helicase activity is essential for controlling the SCR events {#SEC3-5}
--------------------------------------------------------------------------

FANCJ helicase possesses conserved Walker A and B motifs that are essential for ATPase and helicase functions. To test whether the helicase activity of FANCJ is critical for the SCR regulation, we generated shRNA resistant Walker A motif K52A which is defective for ATP binding, and K52R which can bind but not hydrolyze ATP (Figure [6A](#F6){ref-type="fig"}). The steady state levels of these mutants were very similar to wtFANCJ levels (Figure [6E](#F6){ref-type="fig"}). Expression of FANCJ K52A caused ∼4-fold reduction in I-SceI induced HR (Figure [6B](#F6){ref-type="fig"}) and ∼4-fold increase in the ratio of LTGC to overall GC compared to control shRNA or shRNA resistant wt FANCJ (r) cells (Figure [6D](#F6){ref-type="fig"}). In a parallel experiment, we measured the HR in cells expressing FANCJ K52R and found a significant reduction in GFP^+^ cells compared to control cells (Figure [6B](#F6){ref-type="fig"}). The HR events were biased towards ∼2-fold increase in LTGC events in cells expressing FANCJ K52R when compared with control cells (Figure [6B](#F6){ref-type="fig"}--[D](#F6){ref-type="fig"}). To test whether FANCJ Walker motif lysine mutants are competent to bind BRCA1, we performed interaction studies and find that both FANCJ K52A and K52R mutants were proficient in binding to BRCA1 (Figure [6E](#F6){ref-type="fig"}). These data suggest that ATP hydrolysis driven helicase activity of FANCJ is crucial for the SCR regulation.

![Helicase/ATPase activity of FANCJ is required for SCR regulation. (**A**) Schematic diagram of FANCJ depicting the conserved helicase domains (I--VI), NLS motif, Fe--S cluster and the BRCA1 binding domain. The Walker A motif K52 and breast cancer associated P47A mutant residues are indicated. (**B**) I-SceI induced GFP^+^ frequencies in U2OS SCR18 cells transfected with FANCJ shRNA\#1 along with empty vector (EV) and the plasmids that express FANCJ shRNA resistant wtFANCJ, FANCJ K52A, FANCJ K52R and FANCJ P47A. (**C**) Absolute frequencies of BsdR^+^ colonies for the experiment shown in panel B. (**D**) Ratio of LTGC:Overall GC obtained from the data shown in panels B and C. (**E**) Ability of Walker motif mutants of FANCJ interaction with BRCA1. HA-6xHis-FANCJ was measured using HA specific antibody.](gkx586fig6){#F6}

The FANCJ P47A mutation has been identified in a patient with early onset of breast cancer ([@B16]). This mutation resides within the Walker A motif and the purified protein exhibit reduced ATPase and helicase activity ([@B48]). We generated shRNA resistant FANCJ P47A mutant and examined its role in SCR. In contrast to wt protein, a reduced abundance in the FANCJ P47A mutant was observed (Figure [6E](#F6){ref-type="fig"}). Expression of FANCJ P47A pathological mutant caused a ∼4-fold reduction in HR (Figure [6B](#F6){ref-type="fig"}) and \>4-fold increase in the LTGC frequency compared to control cells (Figure [6D](#F6){ref-type="fig"}). The observed HR/SCR defect with this mutant could be largely due to protein instability. However, this mutant was competent to bind BRCA1 (Figure [6E](#F6){ref-type="fig"}).

Iron--sulfur (Fe--S) cluster domain of FANCJ helicase is critical for SCR regulation {#SEC3-6}
------------------------------------------------------------------------------------

Many DNA metabolizing proteins, including DNA glycosylases, primases and helicases contain iron--sulfur (Fe--S) cluster, and this domain appears to have crucial role in the regulation of these enzymes ([@B49],[@B50]). FANCJ helicase also possesses a single Fe--S cluster and has been implicated in the functional activities of FANCJ ([@B49]). Fe--S cluster domain generally contains four conserved cysteine residues which participate in the coordination of Fe metal ion. C283, C298, C310 and C350 are the four conserved cysteines that are present in the Fe--S domain of FANCJ helicase ([Supplementary Figure S3 and S7A](#sup1){ref-type="supplementary-material"}). To investigate the functional role of FANCJ Fe--S cluster in SCR regulation, we generated shRNA resistant FANCJ C350A and C350S mutants. Analyses of the steady state levels of these mutants indicated that FANCJ C350A mutant is unstable ([Supplementary Figure S7E](#sup1){ref-type="supplementary-material"}), whereas FANCJ C350S mutant protein levels were very similar to that of the wt FANCJ ([Supplementary Figure S7E](#sup1){ref-type="supplementary-material"}). Expression of FANCJ C350A resulted in HR/SCR dysfunction ([Supplementary Figure S7B, C and D](#sup1){ref-type="supplementary-material"}), a defect that could be largely attributed to unstable protein. In a parallel experiment, we measured the SCR events with the cells that express FANCJ C350S mutant and found that cysteine to serine substitution largely rescues the SCR defect ([Supplementary Figure S7B--D](#sup1){ref-type="supplementary-material"}). Interaction studies revealed that both FANCJ C350A and C350S mutants are proficient in binding to BRCA1 ([Supplementary Figure S7E](#sup1){ref-type="supplementary-material"}).

Alanine 349 to proline mutation has been identified in a FA patient ([@B18]), and this residue is immediately adjacent to conserved cysteine 350 residue within the Fe--S cluster of FANCJ. To test the role of FANCJ A349P pathological mutant in the SCR regulation, we generated shRNA resistant mutant and analysed the steady state levels. In contrast to wt FANCJ, A349P substitution in FANCJ resulted in partially unstable protein ([Supplementary Figure S7E](#sup1){ref-type="supplementary-material"}). Expression of FANCJ A349P caused ∼4 fold HR/SCR defect, a phenotype that may be largely due to protein instability ([Supplementary Figure S7B--D](#sup1){ref-type="supplementary-material"}). Although this mutant was less stable, it was competent to interact with BRCA1 ([Supplementary Figure S7E](#sup1){ref-type="supplementary-material"}). Together, these data suggest that FANCJ Fe--S cluster is critical for the stability of the protein and may play a role in the DSB repair and in terminating extended repair synthesis during SCR.

DISCUSSION {#SEC4}
==========

Despite FANCJ helicase functions have been implicated in downstream steps of ICL repair and also in the HR mediated repair of DSBs ([@B19],[@B51]), the precise role and the molecular mechanism by which FANCJ controls HR is unclear. Moreover, the factors and the mechanism(s) that regulate the outcome of HR are less understood. In the current study, we demonstrate that FANCJ helicase participates in the repair of DSBs by HR. Strikingly, our data shows that FANCJ but not FANCM determines the fine balance between STGC and LTGC during SCR. Qualitative analyses of the GC tracts reveal that FANCJ terminates extensive repair synthesis during SCR to suppress *GFP*-triplication events. The SCR regulation by FANCJ was dependent on its interaction with BRCA1 tumor suppressor. In addition, the helicase activity of FANCJ was required for efficient HR and suppression of LTGC. These data reveal a novel function of FANCJ helicase in controlling SCR and SCR associated gene amplification/duplications and suggest that these functions may be crucial for the tumor suppression.

The role of FANCJ in SCR regulation and in suppressing LTGC events between sister chromatids appears to be conserved across different species. Indeed, our studies extended to hamster cells reveal that FANCJ fine tunes the HR outcome by terminating the GC in favor of STGC. Consistent with our reporter analysis, Southern blotting data from the BsdR^+^ clones of U2OS cells show those LTGC events are skewed towards more of *GFP*-triplications in FANCJ deficient cells. These observations are made with depletion of FANCJ, and it is highly likely that the proportion of *GFP*-triplications would be further elevated with biallelic mutations in *FANCJ*. Infact, our earlier studies reveal a bimodal distribution of GC tracts with a frequency of 97% of LTGC events resolving as *GFP*-triplication events in cells lacking *RAD51C* ([@B11]).

How does FANCJ regulates overall HR? One possibility is that FANCJ could participate in BRCA1 mediated resection of DSBs. Indeed, a reduction in RPA loading on to chromatin has been observed in FANCJ depleted cells ([@B52]). Moreover, we find that BRCA1 depletion shows more severe reduction in HR than FANCJ depleted cells, indicating that BRCA1 is epistatic to FANCJ. These data suggest that FANCJ participate in the BRCA1 pathway of HR regulation likely by controlling BRCA1 mediated end resection and defective end resection could account for the reduction in overall HR in FANCJ deficient cells. How could we explain the GC bias in favour of LTGC in FANCJ depleted cells? SDSA pathway of DSB repair invokes a model in which displaced nascent strand pairs with the second end of broken chromosome to complete the DSB repair ([@B53]--[@B55]). Conceivably, if the ends are not sufficiently resected, the displaced nascent strand fails to anneal to the second end of the broken chromosome. In this scenario, disengaged nascent strand could reinvade the sister chromatid and initiate repair synthesis. Multiple cycles of this reinvasion could generate GC tracts of several kilobases. A similar mechanism has been proposed for the increase in LTGC events observed in BRCA1 deficient cells ([@B9]). FANCJ could also play an independent and downstream role in displacing the nascent strand from the D-loop and thereby facilitate SDSA mechanism of DSB repair. Consistent with this hypothesis, a biochemical study shows that purified FANCJ helicase unwinds D-loop structures ([@B30]). It is likely that failure in the FANCJ mediated nascent strand disengagement could lead to continued synthesis accounting for increased *GFP*-triplications observed in FANCJ depleted cells. In addition, displacement of RAD51 from nascent strand can be another mechanism by which repair synthesis is terminated during SDSA type of repair. Indeed, FANCJ has been shown to catalyse stripping of RAD51 from the ssDNA ([@B56]).

FANCJ is dispensable for the FANCD2 activation during FA pathway mediated ICL repair and plays a downstream role in repairing the DSBs via HR in the later steps of ICL repair ([@B19]). The role of FANCJ in SCR regulation appears to be independent of its participation in ICL repair. The involvement of FANCJ in ICL repair is dependent on its association with mismatch repair proteins but independent of its interaction with BRCA1 ([@B28],[@B51]). A study demonstrates that BRCA1 plays a distinct role in ICL repair which is independent of its established role in HR ([@B57]). Our data clearly shows that FANCJ participates in the BRCA1 pathway of SCR regulation, suggesting that FANCJ must have evolved with distinct functions in ICL and DSB repair. Recent studies identify multiple roles of FANCJ in genome maintenance by participating in G4 DNA resolution ([@B58]--[@B62]), microsatellite stability ([@B63],[@B64]) and rescuing cells from UV induced lesions ([@B65]) which are independent of its role in FA pathway of ICL repair. FANCM translocase/helicase is crucial for sensing the ICL lesion and loading of FA core complex proteins during ICL repair ([@B22]). Notably, depletion of FANCM did not exhibit LTGC bias during SCR but displayed moderate HR reduction. Recent studies indicate that FANCM interacts with end resection machinery and participate in end resection at ICLs ([@B15],[@B66],[@B67]). The moderate reduction in HR in our assay could be attributed to its role in end resection.

BRCA1 plays a crucial role in determining the choice between HR and NHEJ pathway of DSB repair by participating in the resection of DSBs ([@B68]--[@B71]). FANCJ exists in the BRCA1-B complex by its direct interaction with BRCA1 ([@B16],[@B26]). FANCJ phosphorylation at S990 is essential for its interaction with BRCA1 through BRCT motifs ([@B45],[@B51]). In our studies, expression of shRNA resistant FANCJ S990A mutant caused reduction in overall GC and an increase in LTGC events. This phenotype was partially corrected by the expression of phosphomimicking mutant of FANCJ (FANCJ S990E). This data suggest that FANCJ interaction with BRCA1 is critical for the FANCJ mediated SCR regulation and in the suppression of LTGC during SCR. The FANCJ Q944E mutation has been identified in a breast cancer patient ([@B46]) and we find that expression of this mutant cause defect in HR and an imbalance in the STGC/LTGC. The FANCJ Q944 is in the close proximity to S990 of FANCJ which is required for FANCJ interaction with BRCA1 upon phosphorylation. Perhaps, FANCJ Q944 residue also may be important for its interaction with BRCA1 to engage in end resection step prior to HR initiation. FANCJ lysine 1249 has been shown to be acetylated and this modification contributes to processing of DSB ends to facilitate HR ([@B72]). It will be interesting to test whether FANCJ acetylation is critical for the fine regulation of STGC and LTGC during SCR. Notably, BRCA1-C complex that contains CtIP and MRN complex proteins have been implicated in end resection ([@B73]--[@B76]). It is unclear whether an interplay between BRCA1-B and BRCA1-C complexes exist *in vivo* for the resection of DSB ends. However, further studies are required to delineate the mechanism underlying the BRCA1-FANCJ mediated end resection.

Although lack of BRCA1 and RAD51 paralogs cause HR defect and loss of STGC/LTGC balance ([@B9]--[@B11]), the precise mechanism underlying this phenotype remains to be elucidated. FANCJ being a helicase and effector protein could directly participate in the initial and late stages of HR to influence the HR outcome. Our analysis with Walker A motif lysine mutants revealed interesting phenotypes. FANCJ K52A mutant which lacks ATP binding exhibits a severe reduction in overall GC with a greater increase in LTGC. In contrast, ATP binding competent FANCJ K52R mutant was partially functional. Indeed, FANCJ K52R mutant was devoid of ATPase and helicase activity ([@B30],[@B48],[@B77]) and dominant negative expression of this mutant caused delay in the repair of IR induced DSBs ([@B16]). Notably, FANCJ K52A and K52R mutants were competent to bind BRCA1, suggesting that in addition to BRCA1 interaction, helicase activity of FANCJ is crucial for SCR regulation. It is likely that FANCJ ATPase and helicase activity may be required for BRCA1 mediated end resection or FANCJ could directly participate in nascent strand displacement via its helicase function. FANCJ P47A missense mutation has been identified in a breast cancer patient and this residue is in the highly conserved Walker A motif ([@B16]). The FANCJ P47A mutant protein was defective with ATPase and helicase functions *in vitro* ([@B48]). Consistent with earlier study ([@B16]), we find that FANCJ P47A mutant was unstable and the SCR defect associated with this mutant could be largely attributed to its instability.

Although FANCJ has been considered as a bonafide tumor suppressor, the molecular mechanism by which FANCJ prevents cancer predisposition remains unclear. Data presented in the current study clearly identify that FANCJ helicase restricts pathological outcome of HR by suppressing LTGC. The observed LTGC in FANCJ deficient cells could arise via break-induced replication (BIR) as documented from studies using yeast model organism ([@B78],[@B79]). LTGC could also arise by defective displacement of nascent strand or by defective annealing of displaced nascent strand to the second end of broken chromosome during SDSA mechanism of two ended DSB repair. However, further studies are required to understand the mechanism underlying the LTGC associated with SCR in FANCJ defective cells. Analyses of the breast and ovarian cancer genomes reveal complex genome rearrangements including tandem gene segmental duplications/amplifications ([@B80]--[@B82]). Such duplications are associated with loss of tumor suppressor genes, overexpression of oncogenes, and dysregulated cell cycle and DNA damage repair ([@B82]). Breaks arising during replication appear to be the primary cause of tandem gene segmental duplications/ampifications ([@B36],[@B83]). Indeed, studies from *Escherichia coli* and yeast identified microhomology mediated segmental duplications arising during replicative stress ([@B84]--[@B86]). In addition, a recent study shows that in mammalian cells aberrant termination of HR could induce microhomology mediated complex rearrangements and BIR ([@B87]). It is highly likely that FANCJ could suppress LTGC during repair of breaks induced during replication. Notably, inactivation of *BRCA1/BRCA2* tumor suppressor leads to elevated LTGC at Tus/Ter induced breaks during replication ([@B5]). It will be interesting to test whether FANCJ regulates the balance of STGC/LTGC during repair of replication stress induced DSBs using a similar system.
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